The cyclic adenosine monophosphate elevating medicine, forskolin, reduces neointimal formation and atherogenesis in mice

Neointimal formation and atherogenesis are major vascular complications following percutaneous coronary intervention, and there is lack of pharmacological therapy. This study was aimed to examine the effect of forskolin (FSK), a cyclic adenosine monophosphate (cAMP)‐elevating agent, on vascular resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Huifeng, Ma, Xiaoyan, Chen, Hong, Zhu, Liyuan, Xu, Zhenyu, Li, Qiaoling, Xu, Chuansheng, Zhang, Yuze, Peng, Zekun, Wang, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520276/
https://www.ncbi.nlm.nih.gov/pubmed/32810369
http://dx.doi.org/10.1111/jcmm.15476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520276/
https://www.ncbi.nlm.nih.gov/pubmed/32810369
http://dx.doi.org/10.1111/jcmm.15476

Ejemplares similares